D1 Organ Support

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
D1 Organ Support
Generic name
CARDUUS MARIANUS, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, TARAXACUM OFFICINALE, AVENA SATIVA, CYNARA SCOLYMUS, METHYLCOBALAMIN, MENADIONE, ALPHA-LIPOICUM ACIDUM, CINCHONA OFFICINALIS, HEPAR SUIS, VERATRUM ALBUM, COLON (SUIS), DUODENUM (SUIS), GALLBLADDER (SUIS), INTESTINE (SUIS), LYMPH NODE (SUIS), PANCREAS SUIS, THYMUS (SUIS), THYMUS (SUIS), ALPHA-KETOGLUTARICUM ACIDUM, CHOLESTERINUM, FORMICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, MALICUM ACIDUM, NATRUM OXALACETICUM, SULPHUR, CALCAREA CARBONICA,
Manufacturer
Dr. Donna Restivo DC
Product type
HUMAN OTC DRUG
SPL set ID
e295c5a0-82ca-4fe9-a2e2-9407d81b780e
SPL ID
4c492a1f-e4ec-4308-95c6-324604463ed7
Version
3
Effective date
2024-01-18
Source export date
2026-09-28
Source partition
3
Source file
https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:19:30
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use. Tamper seal: Sealed for your protection. Do not use if seal is broken or missing.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.